Hansoh Pharma Gains NMPA Clinical Approvals for HS-10510, HS-10542, and HS-20118
China-based Hansoh Pharmaceutical Group Co., Ltd (HKG: 3692) announced that it has received separate clinical...
Genor Biopharma Gains NMPA Approval for CDK4/6 Inhibitor Lerociclib in China
China’s Genor Biopharma Co., Ltd (HKG: 6998) announced that it has received marketing clearance from...
Astellas Pharma Licenses Evopoint’s CLDN18.2 ADC for Global Development
Japan-based Astellas Pharma Inc. (TYO: 4503) has entered into a licensing agreement with China-headquartered Evopoint...
Danaher Partners with AstraZeneca to Advance Precision Medicine
US-based science and tech services giant Danaher Corporation (NYSE: DHR) announced a strategic partnership with...
Innovent Biologics Doses First Patient in Phase III Psoriasis Trial for Picankibart
China-based Innovent Biologics, Inc. (HKG: 1801) announced the first subject dosing in a Phase III...
GSK Halts PIVOT-PO Trial Early as Tebipenem HBr Meets Efficacy Targets for cUTI
UK-based pharmaceutical giant GlaxoSmithKline (GSK, NYSE: GSK) announced the early termination of the pivotal Phase...
Amoytop Biotech Wins NMPA Approval for Weekly Inpegsomatropin in Pediatric Growth Deficiency
Xiamen-based Amoytop Biotech Co. Ltd (SHA: 688278) announced that it has received marketing approval from...
Regend Therapeutics Gains NMPA Approval for Phase I/II Study of REGEND003 in Diabetes-Related CKD
Suzhou-based stem cell therapy specialist Regend Therapeutics announced that it has received approval from China’s...
Ganzhou Hemay Pharma Files for HK IPO with SDIC Securities Sponsorship
China-based Ganzhou Hemay Pharmaceutical Co., Ltd. has filed for an initial public offering (IPO) with...
GeneMind Biosciences Closes RMB 280 Million Series C+ Round to Fuel DNA Sequencer Innovation
Shenzhen-based DNA sequencer specialist GeneMind Biosciences Co., Ltd. has reportedly secured RMB 280 million (USD...
Abbott Laboratories Receives FDA Approval for Tendyne TMVR System
US-based medical device giant Abbott Laboratories (NYSE: ABT) announced that it has received marketing approval...
AusperBio Secures $50M in Oversubscribed Series B+ Round to Advance Hepatitis B Therapy
Sino-US liver therapy developer AusperBio announced the successful closing of an oversubscribed Series B+ financing...
BMS Gains European Approval for Opdivo Subcutaneous Formulation
Bristol-Myers Squibb (BMS; NYSE: BMY) announced that the European Commission (EC) has granted approval to...
Novartis’ Fabhalta Approved for Previously Treated PNH Patients in China
The China unit of Swiss pharmaceutical giant Novartis (NYSE: NVS) announced that the National Medical...
InnoCare Pharma Gains NMPA Clinical Approval for BCL2 Inhibitor ICP-248
Beijing-headquartered biotech company InnoCare Pharma (HKG: 9969, SHA: 688428) announced that it has received clinical...
Fosun Pharma and Jiuyuan Gene Partner to Commercialize Biologics in Global Markets
Chinese pharmaceutical firms Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196; HKG: 2196) and Hangzhou...
Lupeng Pharma’s Rocbrutinib Near Approval for Mantle Cell Lymphoma
Guangzhou Lupeng Pharmaceutical Co., Ltd’s rocbrutinib is currently under New Drug Application (NDA) review at...
Viva Biotech Establishes RMB 300M Fund for Early-Stage Pharma Projects
China-based Contract Research Organization (CRO) Viva Biotech (HKG: 1873) announced that its wholly-owned subsidiary, Hangzhou...
Bayer’s Sevabertinib Receives FDA Priority Review for HER2-mutant NSCLC
German pharmaceutical giant Bayer AG (ETR: BAYN) announced that its investigational oral small-molecule tyrosine kinase...
JW Therapeutics’ Carteyva Receives Fourth sBLA for r/r LBCL
JW Therapeutics (HKG: 2126), a clinical-stage cell therapy company co-founded in 2016 by Juno Therapeutics...